How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy

Table 3 Impact of treatments on willigness to recommend (OLS)

Parameter	AZ	J & J	Moderna	Pfizer	Sinopharm	Sputnik-V
	(1)	(2)	(3)	(4)	(5)	(6)
T1: Scientific AZ debate	-0.681	-0.314	-0.112	0.078	-0.492	-0.330
	(0.133)***	(0.128)**	(0.103)	(0.064)	(0.144)***	(0.140)**
T2: Misinformation	0.052	0.160	0.072	0.026	0.427	0.266
	(0.129)	(0.124)	(0.099)	(0.064)	(0.154)***	(0.140)*
T3: Own health	0.078	0.115	0.004	0.031	0.151	0.174
	(0.126)	(0.123)	(0.100)	(0.064)	(0.151)	(0.139)
T4: Public health	0.044	0.077	0.002	-0.007	0.152	0.263
	(0.128)	(0.124)	(0.100)	(0.065)	(0.151)	(0.139)*
Observations	3,318	3,318	3,318	3,318	3,318	3,318
r2	0.8141	0.8148	0.9112	0.9699	0.6120	0.7120
meanT0End	4.9624	4.7207	5.8669	6.6136	3.3068	3.8770
T1vsT2	0.0000	0.0002	0.0761	0.4228	0.0000	0.0000
T1vsT3	0.0000	0.0008	0.2697	0.4675	0.0000	0.0003
T1vsT4	0.0000	0.0023	0.2720	0.1960	0.0000	0.0000
T2vsT3	0.8376	0.7180	0.4956	0.9389	0.0741	0.5104
T2vsT4	0.9476	0.5058	0.4815	0.6164	0.0738	0.9840
T3vsT4	0.7843	0.7589	0.9863	0.5641	0.9952	0.5229
State FE	Yes	Yes	Yes	Yes	Yes	Yes
Basic Controls	Yes	Yes	Yes	Yes	Yes	Yes

Notes: ‘AZ’ refers to AstraZeneca, ‘J & J’ refers to Johnson & Johnson, and ‘Pfizer’ refers to Pfizer/BioNTech. State FE include controls for respondents place of residence (state). Basic controls include respondent’s age, gender, education, and survey specifics (order of vaccine-related questions, platform, device). Robust standard errors used. Standard errors are in parentheses. */**/*** denotes 10/5/1 percent significance levels

ISSN: 1471-2458